Depletion of Skp2 sensitized cells to cisplatin treatment, highlighting a promising approach for Skp2 targeting therapy in nasopharyngeal carcinoma (NPC) treatment [46]. Here, SKP2 is linked to nasopharyngeal carcinoma.